Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans.

Kahn SE, Horber FF, Prigeon RL, Haymond MW, Porte D Jr.

Diabetes. 1993 Jul;42(7):1082-5.

PMID:
8513975
[PubMed - indexed for MEDLINE]
2.

Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans.

Horber FF, Marsh HM, Haymond MW.

Diabetes. 1991 Jan;40(1):141-9.

PMID:
2015969
[PubMed - indexed for MEDLINE]
3.

Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.

Kahn SE, Halban PA.

Diabetes. 1997 Nov;46(11):1725-32.

PMID:
9356018
[PubMed - indexed for MEDLINE]
4.

Elevated plasma proinsulin/insulin ratio is a marker of reduced insulin secretory capacity in healthy young men.

Choi CS, Kim CH, Lee WJ, Park JY, Hong SK, Lee KU.

Horm Metab Res. 1999 Apr;31(4):267-70.

PMID:
10333082
[PubMed - indexed for MEDLINE]
5.

Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.

Røder ME, Schwartz RS, Prigeon RL, Kahn SE.

J Clin Endocrinol Metab. 2000 Jun;85(6):2275-80.

PMID:
10852463
[PubMed - indexed for MEDLINE]
6.

Are insulin and proinsulin independent risk markers for premature coronary artery disease ?

Katz RJ, Ratner RE, Cohen RM, Eisenhower E, Verme D.

Diabetes. 1996 Jun;45(6):736-41.

PMID:
8635646
[PubMed - indexed for MEDLINE]
7.

The IGF-I response to very low rhGH doses is preserved in human ageing.

Arvat E, Ceda G, Ramunni J, Lanfranco F, Aimaretti G, Gianotti L, Broglio F, Ghigo E.

Clin Endocrinol (Oxf). 1998 Dec;49(6):757-63.

PMID:
10209563
[PubMed - indexed for MEDLINE]
8.

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study.

Mauras N, George D, Evans J, Milov D, Abrams S, Rini A, Welch S, Haymond MW.

Metabolism. 2002 Jan;51(1):127-35.

PMID:
11782884
[PubMed - indexed for MEDLINE]
9.

Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.

Bourcigaux N, Arnault-Ouary G, Christol R, Périn L, Charbonnel B, Le Bouc Y.

Clin Ther. 2005 Feb;27(2):246-51.

PMID:
15811488
[PubMed - indexed for MEDLINE]
10.

Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders.

Grill V, Pigon J, Hartling SG, Binder C, Efendic S.

Metabolism. 1990 Mar;39(3):251-8.

PMID:
2407926
[PubMed - indexed for MEDLINE]
11.

True insulin and intact proinsulin levels in acromegalic patients.

Tavares EF, Dalbosco IS, Abucham J, Russo EM.

Eur J Endocrinol. 1996 May;134(5):549-53.

PMID:
8664973
[PubMed - indexed for MEDLINE]
12.

The serum levels of proinsulin and their relationship with IGFBP-1 in obese children.

Kamoda T, Saitoh H, Inudoh M, Miyazaki K, Matsui A.

Diabetes Obes Metab. 2006 Mar;8(2):192-6.

PMID:
16448523
[PubMed - indexed for MEDLINE]
13.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
[PubMed - indexed for MEDLINE]
14.

Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.

Røder ME, Porte D Jr, Schwartz RS, Kahn SE.

J Clin Endocrinol Metab. 1998 Feb;83(2):604-8.

PMID:
9467581
[PubMed - indexed for MEDLINE]
15.

Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH.

Maccario M, Tassone F, Gauna C, Oleandri SE, Aimaretti G, Procopio M, Grottoli S, Pflaum CD, Strasburger CJ, Ghigo E.

Eur J Endocrinol. 2001 Mar;144(3):251-6.

PMID:
11248744
[PubMed - indexed for MEDLINE]
Free Article
16.

Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content.

Cooper MB, Tan KC, Hales CN, Betteridge DJ.

Diabet Med. 1996 Sep;13(9):816-27.

PMID:
8891457
[PubMed - indexed for MEDLINE]
17.

Long-term monitoring of insulin sensitivity in growth hormone-deficient adults on substitutive recombinant human growth hormone therapy.

Giavoli C, Porretti S, Ronchi CL, Cappiello V, Ferrante E, Orsi E, Arosio M, Beck-Peccoz P.

Metabolism. 2004 Jun;53(6):740-3.

PMID:
15164321
[PubMed - indexed for MEDLINE]
18.

Effect of human growth hormone and insulin-like growth factor I on whole-body leucine and estimates of protein metabolism.

Haymond MW, Horber FF, De Feo P, Kahn SE, Mauras N.

Horm Res. 1993;40(1-3):92-4.

PMID:
8300055
[PubMed - indexed for MEDLINE]
19.

Insulin secretion in growth hormone-deficient adults: effects of 24 months' therapy and five days' acute withdrawal of recombinant human growth hormone.

Kamarudin N, Hew FL, Christopher M, Alford J, Rantzau C, Ward G, Alford F.

Metabolism. 1999 Nov;48(11):1387-96.

PMID:
10582546
[PubMed - indexed for MEDLINE]
20.

Systemic and splanchnic metabolic response to exogenous human growth hormone.

Dahn MS, Lange MP.

Surgery. 1998 May;123(5):528-38.

PMID:
9591005
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk